General Information

Government Type

State Agency

Entity

Department of Health and Human Services (DHHS)

Public Body

Pharmacy and Therapeutics Committee

Notice Information

Add Notice to Calendar

Notice Title

State Medicaid Pharmacy and Therapeutics Committee

Notice Tags

Medicaid, Pharmacies

Notice Type(s)

Event Start Date & Time

June 18, 2009 07:00 AM

Event End Date & Time

June 18, 2009 08:30 AM

Event Deadline Date & Time

06/11/09 06:00 PM

Description/Agenda

UTAH DEPARTMENT OF HEALTH STATE MEDICAID PHARMACY AND THERAPEUTICS COMMITTEE Thursday, June 18, 2009 7:00 a.m. to 8:30 a.m. Cannon Health Building ROOM 125 AGENDA Please note that persons who wish to address the P&T Committee may contact Duane Parke (dparke@utah.gov) at least 7 calendar days prior to the meeting. Comments from visitors, while welcome, may be limited due to time constraints 1. Review and Approval of Minutes. 2. DUR Board update Lisa Hulbert Public comment 3. Anti-Parkinson Agents, newer products Dr. John Vu entacapone, tolcapone, rasagiline, selegiline, pramipexole, ropinirole, apomorphone, rotigotine, carbodopa/levodopa/entacapone Public comment Public comment that responds to the materials presented by the Drug Information Service at the University of Utah is most helpful. The foundation documents used for most reviews are prepared by the Oregon Evidence-based Practice Center or the Drug Information Service and are posted in advance on the P&T Committee website Manufacturers are requested to submit any additional materials they would like reviewed as part of the process to: Drug Information Service Attn: Christina Beckwith, PharmD University of Utah Hospitals & Clinics 421 Wakara Way, Suite 204 Salt Lake City, UT 84108 All materials must be clearly labeled that they are submitted for consideration as part of the state of Utah Medicaid Preferred Drug List Program review process. Materials must be received at least 60 days before the scheduled review date. Materials most useful to support the evidence-based process include any new evidence (information from clinical trials or studies when possible) after the Oregon monograph was prepared, unpublished materials the company would like considered as part of the process, or any other materials not likely to be included in a literature search. Topics for coming P&T Committee meetings Jul. Hepatitis C Agents Aug. Cephalosporings, Third Generation, oral Sept. Targets Immunemodulators

Notice of Special Accommodations (ADA)

Duane Parke 801-538-6841

Notice of Electronic or Telephone Participation

No

Meeting Information

Meeting Location

288 North 1460 West
Room 125, Cannon Health Building
Salt Lake City, 84116
Show in Apple Maps Show in Google Maps

Contact Name

Ngan Huynh

Contact Email

nganhuynh@utah.gov

Contact Phone

801-538-6155

Notice Posting Details

Notice Posted On

June 08, 2009 07:52 AM

Notice Last Edited On

June 08, 2009 07:52 AM

Deadline Date

June 11, 2009 06:00 PM

Subscribe by Email

Subscription options will send you alerts regarding future notices posted by this Body.